SPL — Starpharma Holdings Balance Sheet
0.000.00%
Last trade - 00:00- AU$39.30m
- AU$21.50m
- AU$9.76m
- 23
- 22
- 73
- 35
Annual balance sheet for Starpharma Holdings, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 30.1 | 60.5 | 49.9 | 35.2 | 23.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6.09 | 8.44 | 7.84 | 8.23 | 6.34 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 36.7 | 70.8 | 60.7 | 47.1 | 32.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.4 | 2.48 | 5.52 | 4.96 | 3.9 |
| Total Assets | 39.1 | 73.2 | 66.2 | 52.1 | 36.8 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.7 | 10.4 | 10.2 | 14.5 | 6.66 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.75 | 10.9 | 17.8 | 17.3 | 8.7 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 31.3 | 62.3 | 48.4 | 34.8 | 28.1 |
| Total Liabilities & Shareholders' Equity | 39.1 | 73.2 | 66.2 | 52.1 | 36.8 |
| Total Common Shares Outstanding |